Described herein are hydrogels attached to a base with the strength and fatigue comparable to that of cartilage on bone and methods of forming them. The methods and apparatuses described herein may achieve an attachment strength between a hydrogel and a substrate equivalent to the osteochondral junction. In some examples the hydrogel may be a triple-network hydrogel (such as BC-PVA-PAMPS) that is attached to a porous substrate (e.g., a titanium base) with the shear strength and fatigue strength equivalent to that of the osteochondral junction.

Described herein are hydrogels attached to a base with the strength and fatigue comparable to that of cartilage on bone and methods of forming them. The methods and apparatuses described herein may achieve an attachment strength between a hydrogel and a substrate equivalent to the osteochondral junction. In some examples the hydrogel may be a triple-network hydrogel (such as BC-PVA-PAMPS) that is attached to a porous substrate (e.g., a titanium base) with the shear strength and fatigue strength equivalent to that of the osteochondral junction.

An aqueous biopolymer dispersion composition comprising: a biopolymer selected from the group consisting of: polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polylactic acid (PLA), poly(3-hydroxybutyrate) (PHB), polycaprolactone (PCL), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH); poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), polyhydroxyalkanoate (PHA), and mixtures thereof; a stabilising agent selected from the group consisting of: polyvinyl alcohol, fatty alcohol ethoxylates, ethylene oxide/propylene oxide (EO/PO) block copolymers, salts of fatty acids and mixtures thereof; a rheology modifier; a cross linking agent; optional further ingredients; and water.

An aqueous biopolymer dispersion composition comprising: a biopolymer selected from the group consisting of: polybutylene adipate terephthalate (PBAT), polybutylene succinate (PBS), polybutylene succinate adipate (PBSA), polylactic acid (PLA), poly(3-hydroxybutyrate) (PHB), polycaprolactone (PCL), poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH); poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), polyhydroxyalkanoate (PHA), and mixtures thereof; a stabilising agent selected from the group consisting of: polyvinyl alcohol, fatty alcohol ethoxylates, ethylene oxide/propylene oxide (EO/PO) block copolymers, salts of fatty acids and mixtures thereof; a rheology modifier; a cross linking agent; optional further ingredients; and water.

The present invention discloses bioengineered corneal grafts for treating either or both Keratoconus and visual impairment, selected from (i) a corneal Onlay comprises or coated by at least one member of Group A, consisting of biocompatible synthetic materials; at least one member of Group B, consisting of at least one type of biological polymer and optionally, at least one member of Group C, consisting of at least one type of protein and (ii) An intrastromal corneal lenticule graft, configured to mimic native corneal stroma tissue by means of its optical properties, mechanical properties, permeability and interaction with corneal stromal cells; wherein at least one portion of said lenticule comprises or coated by at least one member of Group D, consisting of transparent crosslinked hydrogel; at least one member of Group E, consisting of collagen; collagen methacrylate, recombinant mammal collagen, mammal-sourced collagen; and optionally, at least one member of Group F, consisting of Keratocytes and/or stem cells and any combination thereof. The present invention further discloses compositions, methods for production, implementation and treatment of medical indications by aforesaid corneal graft.

The present invention discloses bioengineered corneal grafts for treating either or both Keratoconus and visual impairment, selected from (i) a corneal Onlay comprises or coated by at least one member of Group A, consisting of biocompatible synthetic materials; at least one member of Group B, consisting of at least one type of biological polymer and optionally, at least one member of Group C, consisting of at least one type of protein and (ii) An intrastromal corneal lenticule graft, configured to mimic native corneal stroma tissue by means of its optical properties, mechanical properties, permeability and interaction with corneal stromal cells; wherein at least one portion of said lenticule comprises or coated by at least one member of Group D, consisting of transparent crosslinked hydrogel; at least one member of Group E, consisting of collagen; collagen methacrylate, recombinant mammal collagen, mammal-sourced collagen; and optionally, at least one member of Group F, consisting of Keratocytes and/or stem cells and any combination thereof. The present invention further discloses compositions, methods for production, implementation and treatment of medical indications by aforesaid corneal graft.

A layer includes polyvinyl alcohol and 20 wt % or more calcium carbonate, based on the total weight of the layer. Another layer includes polyvinyl alcohol and calcium carbonate. A container includes a body that defines an internal cavity capable of holding an article, the body including a layer including polyvinyl alcohol and 20 wt % or more of calcium carbonate, based on the total weight of the layer. Another container includes a layer including polyvinyl alcohol and calcium carbonate.

A layer includes polyvinyl alcohol and 20 wt % or more calcium carbonate, based on the total weight of the layer. Another layer includes polyvinyl alcohol and calcium carbonate. A container includes a body that defines an internal cavity capable of holding an article, the body including a layer including polyvinyl alcohol and 20 wt % or more of calcium carbonate, based on the total weight of the layer. Another container includes a layer including polyvinyl alcohol and calcium carbonate.

A layer includes polyvinyl alcohol and 20 wt % or more calcium carbonate, based on the total weight of the layer. Another layer includes polyvinyl alcohol and calcium carbonate. A container includes a body that defines an internal cavity capable of holding an article, the body including a layer including polyvinyl alcohol and 20 wt % or more of calcium carbonate, based on the total weight of the layer. Another container includes a layer including polyvinyl alcohol and calcium carbonate.

A method for producing a polyvinyl alcohol resin having an absorbance of not less than 0.2 at 280 nm, which includes: melt-kneading a polyvinyl alcohol resin material; extruding the resulting melt-kneaded polyvinyl alcohol resin into a sheet; cooling the resulting polyvinyl alcohol resin sheet; and pulverizing the cooled polyvinyl alcohol resin sheet. The method ensures a higher productivity and an excellent long-run property.